Tag: biomedical
-
Precision Cancer Immunotherapy Biotech Underway
A new company is beginning work on a safer form of cancer immunotherapy that avoids toxic off-target effects, and raising $55 million in venture funds.
-
Fast, Inexpensive Covid-19 Immunity Test Devised
Researchers in Canada developed a simple and inexpensive test for Covid-19 antibodies requiring a pinprick of blood, and returning results in under an hour.
-
Synthetic Antibodies Shown to Control Blood Glucose
A company creating biologics derived from synthetic DNA and genes discovered antibodies that control blood glucose levels in lab animals.
-
Joint Venture Developing Oral Covid-19 Vaccine
Two biotechnology companies are forming a new enterprise to produce a vaccine as a capsule or tablet to protect against Covid-19 infections.
-
Home Sensors, AI Detect Medication Errors
Computer scientists designed a system with radio sensors interpreted by algorithms that indicate when residents make mistakes with their medication devices.
-
Engineered Macrophage Cells Tested in Cancer Trial
A clinical trial is underway testing immune system cells called macrophages, with added cancer-killing proteins, as a treatment for solid tumor cancers.
-
Vaccine Spin-Off Raises $168 Million in New Funds
A developer of vaccines, including a leading Covid-19 vaccine, and cancer immunotherapies, is raising $168 million in its second venture round.
-
Trial Tests Non-Invasive Brain Bleeding Scanner
A clinical trial is underway testing a device worn like a helmet that scans brain tissue for internal bleeding with radio-frequency waves.
-
FDA Clears Covid-19 Nasal Spray/Drops Vaccine Trial
A company developing vaccines delivered through the nose received FDA clearance to begin a clinical trial of its vaccine protecting against Covid-19 infections.
-
Molecular Diagnostics Company Acquired in $1.8B Deal
GenMark Diagnostics, a developer of diagnostics systems using genomic analysis, was acquired by drug maker Roche in a deal valued at $1.8 billion.